Skip to main content

ABVX · ABIVAX · Financials

80.9000 EUR 15-min delayed · Oct 5, 15:35 UTC
Market Cap
7.32B EUR
Shares
87.25M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
4.57M -63.3%
FY2025 Revenue FY2021–FY2025
Net Income
-336.1M -90.7%
FY2025 Net Income FY2021–FY2025
Operating Margin
-5384.16% -3994.6pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-161.13M -4.6%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
EUR 4.57M 12.45M 4.62M 4.58M 11.96M
EUR 177.76M 146.53M 103.18M 48.3M 47.78M
EUR 5.19M 5.95M 6.43M 0 0
EUR 67.67M 32.95M 22.39M 7.49M 5.58M
EUR -246.06M -172.98M -127.38M -64.84M -41.4M
EUR 111.74M 16.99M 27.88M 7.02M 3.56M
EUR -330.25M -176.24M -147.74M -60.74M -42.45M
EUR 5.85M 0 0 0 0
EUR -336.1M -176.24M -147.74M -60.74M -42.45M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.